• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

巴伐利亚州皮肤科医生密度与恶性黑色素瘤发病率和死亡率的关系。

Incidence and Mortality of Malignant Melanoma in Relation to Dermatologist Density in Bavaria.

机构信息

Universitätsklinikum Regensburg, Klinik und Poliklinik für Dermatologie, Regensburg, Germany.

Institut und Poliklinik für Arbeits-, Sozial- und Umweltmedizin, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.

出版信息

Adv Ther. 2021 Nov;38(11):5548-5556. doi: 10.1007/s12325-021-01917-1. Epub 2021 Oct 1.

DOI:10.1007/s12325-021-01917-1
PMID:34596866
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8520867/
Abstract

INTRODUCTION

Malignant melanoma is an aggressive skin tumor with a good prognosis when treated in an early tumor stage, but has a poor prognosis with distant metastases. The incidence of malignant melanoma has increased continuously over the last decades, with little change in mortality. One explanation for this is that melanomas are increasingly detected in early stages, especially after the establishment of statutory skin cancer screening in 2008, which allows a free skin examination every 2 years for people older than 35 years.

METHODS

In this study incidence and mortality of malignant melanoma were correlated with the dermatologist density in Bavarian administrative regions. In addition, the incidence data were compared before and after the introduction of statutory skin cancer screening.

RESULTS

There was a significant correlation between the incidence of malignant melanoma and dermatologist density (r = 0.258, p = 0.044), but no correlation between mortality and dermatologist density (r = 0.201, p = 0.121). Similarly, the increase of malignant melanoma incidence following the introduction of statutory skin cancer screening in 2008 was independent of dermatologist density (r = 0.021, p = 0.873).

CONCLUSION

The dermatologist density in Bavaria correlates positively with the incidence of malignant melanoma. Despite an increased incidence, mortality was not elevated in the respective administrative regions.

摘要

简介

恶性黑色素瘤是一种侵袭性皮肤肿瘤,早期肿瘤阶段治疗预后良好,但发生远处转移则预后较差。在过去几十年中,恶性黑色素瘤的发病率不断增加,而死亡率变化不大。对此的一种解释是,黑色素瘤在早期阶段的检出率越来越高,尤其是自 2008 年法定皮肤癌筛查制度建立以来,该制度允许 35 岁以上人群每两年免费进行一次皮肤检查。

方法

本研究将巴伐利亚行政区的皮肤科医生密度与恶性黑色素瘤的发病率和死亡率相关联。此外,还比较了法定皮肤癌筛查制度引入前后的发病率数据。

结果

恶性黑色素瘤的发病率与皮肤科医生密度呈显著正相关(r=0.258,p=0.044),但死亡率与皮肤科医生密度无相关性(r=0.201,p=0.121)。同样,2008 年法定皮肤癌筛查制度引入后恶性黑色素瘤发病率的增加与皮肤科医生密度无关(r=0.021,p=0.873)。

结论

巴伐利亚州的皮肤科医生密度与恶性黑色素瘤的发病率呈正相关。尽管发病率有所增加,但各行政区的死亡率并未升高。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d121/8520867/eb5a376891dd/12325_2021_1917_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d121/8520867/de02c6288a90/12325_2021_1917_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d121/8520867/eb5a376891dd/12325_2021_1917_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d121/8520867/de02c6288a90/12325_2021_1917_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d121/8520867/eb5a376891dd/12325_2021_1917_Fig2_HTML.jpg

相似文献

1
Incidence and Mortality of Malignant Melanoma in Relation to Dermatologist Density in Bavaria.巴伐利亚州皮肤科医生密度与恶性黑色素瘤发病率和死亡率的关系。
Adv Ther. 2021 Nov;38(11):5548-5556. doi: 10.1007/s12325-021-01917-1. Epub 2021 Oct 1.
2
3
Melanoma incidence and patient compliance in a targeted melanoma screening intervention. One-year follow-up in a large French cohort of high-risk patients.靶向黑色素瘤筛查干预中的黑色素瘤发病率及患者依从性。对一大群法国高危患者进行的为期一年的随访。
Eur J Gen Pract. 2015 Jun;21(2):124-30. doi: 10.3109/13814788.2014.949669. Epub 2014 Aug 20.
4
Melanoma screening: A plan for improving early detection.黑色素瘤筛查:改善早期检测的计划。
Ann Med. 2016;48(3):142-8. doi: 10.3109/07853890.2016.1145795. Epub 2016 Feb 25.
5
Melanoma prognosis in the United States: Identifying barriers for improved care.美国的黑色素瘤预后:确定改善护理的障碍。
J Am Acad Dermatol. 2019 May;80(5):1256-1262. doi: 10.1016/j.jaad.2019.01.003. Epub 2019 Jan 17.
6
Systematic skin cancer screening in Northern Germany.在德国北部进行系统性皮肤癌筛查。
J Am Acad Dermatol. 2012 Feb;66(2):201-11. doi: 10.1016/j.jaad.2010.11.016. Epub 2011 Nov 8.
7
Association of increased dermatologist density with lower melanoma mortality.皮肤科医生密度增加与黑色素瘤死亡率降低之间的关联。
Arch Dermatol. 2012 Feb;148(2):174-8. doi: 10.1001/archdermatol.2011.345.
8
Cutaneous melanoma: public health approach to early detection.皮肤黑色素瘤:早期检测的公共卫生方法。
Dermatol Ther. 2006 Jan-Feb;19(1):26-31. doi: 10.1111/j.1529-8019.2005.00053.x.
9
A Reminder of Skin Cancer During the COVID-19 Pandemic.新冠疫情期间对皮肤癌的提醒。
Acta Dermatovenerol Croat. 2021 Apr;291(1):58.
10
Does skin cancer screening save lives? A detailed analysis of mortality time trends in Schleswig-Holstein and Germany.皮肤癌筛查是否能拯救生命?对石勒苏益格-荷尔斯泰因州和德国死亡率时间趋势的详细分析。
Cancer. 2016 Feb 1;122(3):432-7. doi: 10.1002/cncr.29755. Epub 2015 Oct 19.

引用本文的文献

1
Impact of Patient's Age and Physician's Professional Background on the Number Needed to Treat in Malignant Melanoma Detection.患者年龄和医生专业背景对恶性黑色素瘤检测中需治疗人数的影响。
Cancers (Basel). 2024 Nov 29;16(23):4014. doi: 10.3390/cancers16234014.
2
Skin cancer in Germany: Characterising screening, prevalence and mortality from a spatial perspective.德国的皮肤癌:从空间角度描述筛查、流行和死亡率。
PLoS One. 2024 Jul 5;19(7):e0305915. doi: 10.1371/journal.pone.0305915. eCollection 2024.
3
Degree of Actinic Elastosis Is a Surrogate of Exposure to Chronic Ultraviolet Radiation and Correlates More Strongly with Cutaneous Squamous Cell Carcinoma than Basal Cell Carcinoma.

本文引用的文献

1
[Primary prevention in the context of skin cancer screening].[皮肤癌筛查背景下的一级预防]
Hautarzt. 2019 Jun;70(6):432-437. doi: 10.1007/s00105-019-4355-2.
2
Time trends in incidence and mortality of cutaneous melanoma in Germany.德国皮肤黑色素瘤发病率和死亡率的时间趋势。
J Eur Acad Dermatol Venereol. 2019 Jul;33(7):1272-1280. doi: 10.1111/jdv.15322. Epub 2019 Apr 17.
3
Incidence and characteristics of thick second primary melanomas: a study of the German Central Malignant Melanoma Registry.厚发性第二原发黑色素瘤的发生率和特征:德国中央恶性黑色素瘤登记处的研究。
光化性弹性组织变性的程度是慢性紫外线辐射暴露的替代指标,且与皮肤鳞状细胞癌的相关性比基底细胞癌更强。
Life (Basel). 2023 Mar 17;13(3):811. doi: 10.3390/life13030811.
4
Influencing Mechanism of Nod-Like Receptor Protein 3 Inflammasome Activation in A375 Cell Activity in Human Cutaneous Malignant Melanoma.Nod-样受体蛋白 3 炎性小体激活对人皮肤恶性黑素瘤 A375 细胞活性的影响机制。
J Immunol Res. 2022 Jul 15;2022:7420330. doi: 10.1155/2022/7420330. eCollection 2022.
J Eur Acad Dermatol Venereol. 2019 Jan;33(1):63-70. doi: 10.1111/jdv.15194. Epub 2018 Aug 14.
4
Epidemiology of skin cancer in the German population: impact of socioeconomic and geographic factors.德国人群皮肤癌的流行病学:社会经济和地理因素的影响。
J Eur Acad Dermatol Venereol. 2018 Nov;32(11):1906-1913. doi: 10.1111/jdv.14990. Epub 2018 Jul 17.
5
A Novel Alternate Dosing of Vismodegib for Treatment of Patients With Advanced Basal Cell Carcinomas.维莫德吉治疗晚期基底细胞癌患者的一种新型交替给药方案。
JAMA Dermatol. 2017 Apr 1;153(4):321-322. doi: 10.1001/jamadermatol.2016.5058.
6
Incidence trends and clinical-pathological characteristics of invasive cutaneous melanoma from 1980 to 2010 in the Canton of Zurich, Switzerland.1980年至2010年瑞士苏黎世州侵袭性皮肤黑色素瘤的发病趋势及临床病理特征
Melanoma Res. 2017 Apr;27(2):145-151. doi: 10.1097/CMR.0000000000000312.
7
Interval cancers after skin cancer screening: incidence, tumour characteristics and risk factors for cutaneous melanoma.皮肤癌筛查后的间期癌:皮肤黑色素瘤的发病率、肿瘤特征及危险因素
Br J Cancer. 2017 Jan 17;116(2):253-259. doi: 10.1038/bjc.2016.390. Epub 2016 Nov 29.
8
[Care for skin cancer in Germany : Provision and providers].[德国的皮肤癌护理:服务提供与提供者]
Hautarzt. 2016 Jul;67(7):544-8. doi: 10.1007/s00105-016-3816-0.
9
Individual and ecological factors associated with early detection of nodular melanoma in the United States.与美国结节性黑色素瘤早期检测相关的个体和生态因素。
Melanoma Res. 2014 Apr;24(2):165-71. doi: 10.1097/CMR.0000000000000049.
10
Association of increased dermatologist density with lower melanoma mortality.皮肤科医生密度增加与黑色素瘤死亡率降低之间的关联。
Arch Dermatol. 2012 Feb;148(2):174-8. doi: 10.1001/archdermatol.2011.345.